Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Kathleen M. Olson, MD

Advertisement

Articles by Kathleen M. Olson, MD

 ktsdesign - stock.adobe.com

Urologic implications of Lynch syndrome

ByKathleen M. Olson, MD,Mark D. Tyson, MD, MPH,Alan H. Bryce, MD
December 1st 2020

Research indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.

Advertisement

Latest Updated Articles

  •  ktsdesign - stock.adobe.com
    Urologic implications of Lynch syndrome

    December 1st 2020



Advertisement
Advertisement

Trending on Urology Times

1

Patient priorities guide treatment choice in BCG-unresponsive NMIBC

2

Pasritamig combination yields 73% PSA response rate in phase 1 mCRPC study

3

FAQ: ASTRO guideline on hypofractionated radiation therapy for localized prostate cancer

4

Nogapendekin alfa inbakicept plus BCG meets primary end point in BCG-naïve NMIBC

5

Modern BCG outperforms historic benchmarks in high-risk NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us